MedTrace Logo

Informed Consent and Clinical Trials

NCT01635842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-03-03

No results posted yet for this study

Summary

To understand the patients' meaning of the informed consent process in clinical trials.

Objective of the study is:

* to assess, in a cohort of subjects included in clinical trials, whether the information and the informed Consent Forms conveyed to the patients have been understood
* to assess whether the choice to participate in a clinical trial is informed and aware

Conditions

  • Informed Consent

Sponsors & Collaborators

  • Azienda Usl di Bologna

    lead OTHER_GOV

Principal Investigators

  • Paola Mosconi, Biology · Ethics Committee AUSL of Bologna

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01635842 on ClinicalTrials.gov